STRATA Skin Sciences, Inc. (NASDAQ:SSKN – Get Free Report) saw a large decrease in short interest in September. As of September 15th, there was short interest totalling 2,600 shares, a decrease of 25.7% from the August 31st total of 3,500 shares. Based on an average daily volume of 24,800 shares, the short-interest ratio is presently 0.1 days. Approximately 0.1% of the company’s shares are sold short.
STRATA Skin Sciences Stock Down 7.8 %
NASDAQ:SSKN traded down $0.25 on Friday, hitting $2.95. The stock had a trading volume of 19,090 shares, compared to its average volume of 11,680. The company has a quick ratio of 0.92, a current ratio of 1.14 and a debt-to-equity ratio of 1.59. STRATA Skin Sciences has a 52 week low of $2.51 and a 52 week high of $7.10. The business’s fifty day moving average is $3.14 and its 200 day moving average is $3.71. The company has a market cap of $10.35 million, a PE ratio of -0.89 and a beta of 1.37.
STRATA Skin Sciences (NASDAQ:SSKN – Get Free Report) last issued its earnings results on Wednesday, August 14th. The medical device company reported ($0.03) earnings per share for the quarter. STRATA Skin Sciences had a negative return on equity of 50.45% and a negative net margin of 25.40%. The firm had revenue of $8.44 million for the quarter. On average, equities research analysts expect that STRATA Skin Sciences will post -1 EPS for the current fiscal year.
Insider Activity at STRATA Skin Sciences
Institutional Inflows and Outflows
An institutional investor recently raised its position in STRATA Skin Sciences stock. Azzad Asset Management Inc. ADV increased its holdings in STRATA Skin Sciences, Inc. (NASDAQ:SSKN – Free Report) by 289.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 67,000 shares of the medical device company’s stock after acquiring an additional 49,800 shares during the period. Azzad Asset Management Inc. ADV owned about 0.19% of STRATA Skin Sciences worth $25,000 at the end of the most recent quarter. 32.43% of the stock is currently owned by institutional investors.
About STRATA Skin Sciences
STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
Featured Stories
- Five stocks we like better than STRATA Skin Sciences
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- Technology Stocks Explained: Here’s What to Know About Tech
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- What Are the FAANG Stocks and Are They Good Investments?
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.